Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,043 | -29,103 | -11,151 | -16,745 | -10,583 |
| Depreciation Amortization | 664 | 2,267 | 1,634 | 1,049 | 509 |
| Income taxes - deferred | N/A | 14 | N/A | N/A | N/A |
| Accounts receivable | -3,820 | -4,529 | -8,161 | -2,805 | -495 |
| Other Working Capital | -4,361 | 13,256 | 7,740 | -1,950 | -6,882 |
| Other Operating Activity | -180 | 5,656 | 4,273 | -638 | 5,383 |
| Operating Cash Flow | $-15,740 | $-12,439 | $-5,665 | $-21,090 | $-12,068 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 343 | -53,043 | -32,647 | -31,449 | -1,803 |
| PPE Investments | -681 | -2,782 | -1,956 | -1,173 | -527 |
| Purchase Sale Intangibles | N/A | 1,000 | 1,000 | 1,000 | N/A |
| Other Investing Activity | 0 | 1,000 | 1,000 | 1,000 | 0 |
| Investing Cash Flow | $-338 | $-54,824 | $-33,603 | $-31,622 | $-2,330 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70 | 84,501 | 84,342 | 82,465 | 0 |
| Other Financing Activity | 0 | -150 | -150 | 0 | 0 |
| Financing Cash Flow | $70 | $84,352 | $84,192 | $82,465 | $N/A |
| Beginning Cash Position | 57,633 | 40,544 | 40,544 | 40,544 | 40,544 |
| End Cash Position | 41,624 | 57,633 | 85,469 | 70,298 | 26,146 |
| Net Cash Flow | $-16,009 | $17,089 | $44,925 | $29,754 | $-14,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,740 | -12,439 | -5,665 | -21,090 | -12,068 |
| Capital Expenditure | -681 | -2,782 | -1,956 | -1,173 | -527 |
| Free Cash Flow | -16,421 | -15,220 | -7,621 | -22,263 | -12,595 |